The effect of treatment as usual on major depressive disorder: A meta-analysis

Journal of Affective Disorders

Volumn 210, Issue , 2017, Pages 72-81

  Kolovos, Spyros ^a   van Tulder, Maurits W ^a   Cuijpers, Pim ^a   Prigent, Amélie ^b   Chevreul, Karine ^b,c   Riper, Heleen ^a,d   Bosmans, Judith E ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Health economic models; Major depression; Meta analysis; Treatment as usual

Indexed keywords

BEHAVIOR CHANGE; COCHRANE LIBRARY; DETERIORATION; HUMAN; MAJOR DEPRESSION; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; PSYCHOTHERAPY; PSYCINFO; PUBLISHING; RANDOMIZED CONTROLLED TRIAL (TOPIC); REMISSION; REVIEW; SHORT COURSE THERAPY; SYSTEMATIC REVIEW; SYSTEMATIC REVIEW (TOPIC); TREATMENT OUTCOME; TREATMENT RESPONSE; PROCEDURES; PSYCHOLOGY;

DEPRESSIVE DISORDER, MAJOR; HUMANS; PSYCHOTHERAPY; TREATMENT OUTCOME;

EID: 85007047689     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2016.12.013     Document Type: Review

References (52)

1. Aalabaf‐Sabaghi, M., Decision modelling for health economic evaluation. J. Epidemiol. Community Health, 61, 2007 (839–839).
2. Association, A.P., 2006. American Psychiatric Association Practice Guidelines for the treatment of psychiatric disorders: compendium 2006. American Psychiatric Pub.
3. Balk, E.M., Earley, A., Patel, K., Trikalinos, T.A., Dahabreh, I.J., 2012. Empirical assessment of within-arm correlation imputation in trials of continuous outcomes.
4. Barrett, B., Byford, S., Knapp, M., Evidence of cost-effective treatments for depression: a systematic review. J. Affect. Disord. 84 (2005), 1–13.
5. Borenstein, M., Hedges, L.V., Higgins, J.P., Rothstein, H.R., Introduction to Meta-analysis. 2011, John Wiley & Sons.
6. Burns, T., End of the road for treatment-as-usual studies?. Br. J. Psychiatry.: J. Ment. Sci. 195 (2009), 5–6.
7. Burns, T., Priebe, S., Mental health care systems and their characteristics: a proposal. Acta Psychiatr. Scand. 94 (1996), 381–385.
8. Cohen, J., Statistical Power Analysis for the Behavioral Sciences. 2013, Academic press.
9. Cramer, H., Salisbury, C., Conrad, J., Eldred, J., Araya, R., Group cognitive behavioural therapy for women with depression: pilot and feasibility study for a randomised controlled trial using mixed methods. BMC Psychiatry, 11, 2011, 82.
10. Cuijpers, P., Karyotaki, E., Weitz, E., Andersson, G., Hollon, S.D., van Straten, A., The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. J. Affect. Disord. 159 (2014), 118–126.
11. Cuijpers, P., van Straten, A., Andersson, G., van Oppen, P., Psychotherapy for depression in adults: a meta-analysis of comparative outcome studies. J. Consult. Clin. Psychol. 76 (2008), 909–922.
12. Cuijpers, P., van Straten, A., Bohlmeijer, E., Hollon, S.D., Andersson, G., The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol. Med. 40 (2010), 211–223.
13. Cuijpers, P., van Straten, A., van Oppen, P., Andersson, G., Are psychological and pharmacologic interventions equally effective in the treatment of adult depressive disorders? A meta-analysis of comparative studies. J. Clin. Psychiatry 69 (2008), 1675–1685 (quiz 1839–1641).
14. Davidson, J.R., Major depressive disorder treatment guidelines in America and Europe. J. Clin. Psychiatry, 71(Suppl E1), 2010, e04.
15. Donker, T., Blankers, M., Hedman, E., Ljotsson, B., Petrie, K., Christensen, H., Economic evaluations of Internet interventions for mental health: a systematic review. Psychol. Med. 45 (2015), 3357–3376.
16. Duval, S., Tweedie, R., Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis. Biometrics 56 (2000), 455–463.
17. Ebert, D.D., Donkin, L., Andersson, G., Andrews, G., Berger, T., Carlbring, P., Rozenthal, A., Choi, I., Laferton, J.A., Johansson, R., Kleiboer, A., Lange, A., Lehr, D., Reins, J.A., Funk, B., Newby, J., Perini, S., Riper, H., Ruwaard, J., Sheeber, L., Snoek, F.J., Titov, N., Unlu Ince, B., van Bastelaar, K., Vernmark, K., van Straten, A., Warmerdam, L., Salsman, N., Cuijpers, P., Does Internet-based guided-self-help for depression cause harm? An individual participant data meta-analysis on deterioration rates and its moderators in randomized controlled trials. Psychol. Med. 46 (2016), 2679–2693.
18. Englewood, Comprehensive meta-analysis (version 2). Biostatistics, 2014.
19. Frank, E., Prien, R.F., Jarrett, R.B., Keller, M.B., Kupfer, D.J., Lavori, P.W., Rush, A.J., Weissman, M.M., Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Arch. Gen. Psychiatry 48 (1991), 851–855.
20. Greenberg, P.E., Fournier, A.-A., Sisitsky, T., Pike, C.T., Kessler, R.C., The economic burden of adults with major depressive disorder in the United States (2005 and 2010). J. Clin. Psychiatry 76 (2015), 155–162.
21. Harbord, R., Higgins, J., Metareg: Stata module to perform meta-analysis regression. Stat. Softw. Compon., 2009.
22. Hasin, D.S., Goodwin, R.D., Stinson, F.S., Grant, B.F., Epidemiology of major depressive disorder: results from the National Epidemiologic Survey on Alcoholism and Related Conditions. Arch. Gen. Psychiatry 62 (2005), 1097–1106.
23. Health, N.C.Cf.M., Depression: the treatment and management of depression in adults (updated edition). Br. Psychol. Soc., 2010.
24. Hedges, L., Olkin, I., Statistical Methods for Meta-Analysis. 1985, San Diego.
25. Hedges, L., Vevea, J., Fixed-and random-effects models in meta-analysis. Psychol. Methods 3 (1998), 486–504.
26. Higgins, Green, S., 2011. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration.
27. Higgins, Thompson, S.G., Deeks, J.J., Altman, D.G., Measuring inconsistency in meta-analyses. BMJ (Clin. Res. Ed. ) 327 (2003), 557–560.
28. Higgins, J.P., Altman, D.G., Gotzsche, P.C., Juni, P., Moher, D., Oxman, A.D., Savovic, J., Schulz, K.F., Weeks, L., Sterne, J.A., The Cochrane collaboration's tool for assessing risk of bias in randomised trials. BMJ (Clin. Res. Ed. ), 343, 2011, d5928.
29. Ioannidis, J.P.A., Patsopoulos, N.A., Evangelou, E., Uncertainty in heterogeneity estimates in meta-analyses. BMJ: Br. Med. J. 335 (2007), 914–916.
30. Jacobson, N.S., Truax, P., Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J. Consult. Clin. Psychol. 59 (1991), 12–19.
31. Jacobson, N.S., Truax, P., Clinical significance: a statistical approach to defining meaningful change in psychotherapy research. J. Consult. Clin. Psychol. 59 (1991), 12–19.
32. Kemmeren, L.L., van Schaik, D.J., Riper, H., Kleiboer, A.M., Bosmans, J.E., Smit, J.H., Effectiveness of blended depression treatment for adults in specialised mental healthcare: study protocol for a randomised controlled trial. BMC Psychiatry, 16, 2016, 113.
33. Kolovos, S., Kleiboer, A., Cuijpers, P., Effect of psychotherapy for depression on quality of life: meta-analysis. Br. J. Psychiatry, 2016.
34. Löfholm, C.A., Brännström, L., Olsson, M., Hansson, K., Treatment-as-usual in effectiveness studies: what is it and does it matter?. Int. J. Soc. Welf. 22 (2013), 25–34.
35. Mathers, C.D., Loncar, D., Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med., 3, 2006, e442.
36. McDermott, B., Baigent, M., Chanen, A., Graetz, B., Hayman, N., Newman, N., Parikh, N., Peirce, B., Proimos, J., Smalley, T., Spence, S., 2010. Clinical practice guidelines: depression in adolescents and young adults, beyondblue: the national depression initiative, Melbourne.
37. Mohr, D.C., Ho, J., Hart, T.L., Baron, K.G., Berendsen, M., Beckner, V., Cai, X., Cuijpers, P., Spring, B., Kinsinger, S.W., Schroder, K.E., Duffecy, J., Control condition design and implementation features in controlled trials: a meta-analysis of trials evaluating psychotherapy for depression. Transl. Behav. Med. 4 (2014), 407–423.
38. Moussavi, S., Chatterji, S., Verdes, E., Tandon, A., Patel, V., Ustun, B., Depression, chronic diseases, and decrements in health: results from the world healthhealth surveys. Lancet 370 (2007), 851–858.
39. Orsini, N., Bottai, M., Higgins, J., Buchan, I., Heterogi: stata module to quantify heterogeneity in a meta-analysis. Stat. Softw. Compon., 2006.
40. Papakostas, G.I., Petersen, T., Mahal, Y., Mischoulon, D., Nierenberg, A.A., Fava, M., Quality of life assessments in major depressive disorder: a review of the literature. Gen. Hosp. Psychiatry 26 (2004), 13–17.
41. Patten, S.B., Williams, J.V., Lavorato, D.H., Modgill, G., Jette, N., Eliasziw, M., Major depression as a risk factor for chronic disease incidence: longitudinal analyses in a general population cohort. Gen. Hosp. Psychiatry 30 (2008), 407–413.
42. Petrou, S., Gray, A., Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ (Clin. Res. Ed., 342, 2011, d1766.
43. Rush, A.J., Kraemer, H.C., Sackeim, H.A., Fava, M., Trivedi, M.H., Frank, E., Ninan, P.T., Thase, M.E., Gelenberg, A.J., Kupfer, D.J., Regier, D.A., Rosenbaum, J.F., Ray, O., Schatzberg, A.F., Report by the ACNP task force on response and remission in major depressive disorder. Neuropsychopharmacol.: Off. Publ. Am. Coll. Neuropsychopharmacol. 31 (2006), 1841–1853.
44. Saarni, S.I., Viertiö, S., Perälä, J., Koskinen, S., Lönnqvist, J., Suvisaari, J., Quality of life of people with schizophrenia, bipolar disorder and other psychotic disorders. Br. J. Psychiatry 197 (2010), 386–394.
45. Santa Ana, E.J., Martino, S., Ball, S.A., Nich, C., Frankforter, T.L., Carroll, K.M., What is usual about "treatment-as-usual"? Data from two multisite effectiveness trials. J. Subst. Abus. Treat. 35 (2008), 369–379.
46. Schulz, K.F., Altman, D.G., Moher, D., CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann. Intern Med 152 (2010), 726–732.
47. Simmonds, M.C., Higginsa, J.P., Stewartb, L.A., Tierneyb, J.F., Clarke, M.J., Thompson, S.G., Meta-analysis of individual patient data from randomized trials: a review of methods used in practice. Clin. Trials 2 (2005), 209–217.
48. Viechtbauer, W., Bias and efficiency of meta-analytic variance estimators in the random-effects model. J. Educ. Behav. Stat. 30 (2005), 261–293.
49. Watts, S.E., Turnell, A., Kladnitski, N., Newby, J.M., Andrews, G., Treatment-as-usual (TAU) is anything but usual: a meta-analysis of CBT versus TAU for anxiety and depression. J. Affect. Disord. 175 (2015), 152–167.
50. Weinstein, M.C., Recent developments in decision-analytic modelling for economic evaluation. PharmacoEconomics 24 (2006), 1043–1053.
51. Whiteford, H.A., Harris, M.G., McKeon, G., Baxter, A., Pennell, C., Barendregt, J.J., Wang, J., Estimating remission from untreated major depression: a systematic review and meta-analysis. Psychol. Med. 43 (2013), 1569–1585.
52. Wittchen, H.U., Jacobi, F., Rehm, J., Gustavsson, A., Svensson, M., Jonsson, B., Olesen, J., Allgulander, C., Alonso, J., Faravelli, C., Fratiglioni, L., Jennum, P., Lieb, R., Maercker, A., van Os, J., Preisig, M., Salvador-Carulla, L., Simon, R., Steinhausen, H.C., The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur. Neuropsychopharmacol.: J. Eur. Coll. Neuropsychopharmacol. 21 (2011), 655–679.